摩根士丹利表示，金沙中国次季的经调整EBITDA为5.59亿美元(未调整前EBITDA为5.66亿美元)，基本符合下调后的市场共识预期。伦敦人EBITDA为2.05亿美元，按季增长34%、按年增长99%，但其他项目(特别是巴黎人按季下降33%)表现极为疲软。中场市场占有率按季上升90个基点至24.3%。大摩指出，金沙中国2025年上半年年化计算的企业EBITDA为20.2亿美元，较2025年市场共识预期低12%。该行维持对其“增持”评级及目标价17.5港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.